Nominations Open for Human Animal Bond Innovation Awards

The Human Animal Bond Research Institute (HABRI) and Synchrony (NYSE: SYF), a leading consumer finance company, today announced a strategic partnership to advance the companies’ shared goal of strengthening the human-animal bond. “At Synchrony, we’re continually looking for ways to equip pet parents and veterinarians with the knowledge, resources and financial solutions to provide all pets with the care they need, over the course of their lifetime,” said Boo Larsen, Senior Vice President and General Manager, Veterinary and Pet Care, Synchrony. “By joining forces with HABRI, we hope to help everyone in the relationship with the animal truly understand the mutually beneficial power of the bond, which will in turn lead to better veterinary care.”[1] Synchrony is committed to empowering the health and wellness of people and their families, including their pets, through its flexible financial solutions including the CareCredit health and wellness credit card and Pets Best, as well as partnerships such as this one with HABRI.  HABRI’s efforts to demonstrate and substantiate the positive impact of this special bond on the health of pets, individuals, families and communities align perfectly with Synchrony. Synchrony will help HABRI fulfill its mission of building the human-animal bond by: Funding HABRI’s impactful research that documents the positive benefits of companion animals for personal and public health and addresses major industry issues. Amplifying HABRI’s science-based education to CareCredit’s network of 25,000 veterinary providers – which reaches 95% of veterinary university hospitals and ~75% of veterinary hospitals nationwide – to increase public awareness of the human-animal bond’s essential role in human and animal health and wellness. Participating in HABRI’s public policy initiatives and advocating for legislative solutions that support pet owners and help increase access to pet care. Synchrony executives recently participated...

The Human Animal Bond Research Institute (HABRI) announced today the online publication of a study titled, “The Effect of a PTSD Service Dog on Military Veterans’ Medication Regimens: A Cross-Sectional Pilot Study”, in the journal Anthrozoos. Findings of the study, conducted by researchers at the Purdue University College of Veterinary Medicine and the Purdue University College of Pharmacy, found no significant differences between post-9/11 U.S. veterans living with post-traumatic stress disorder (PTSD) who were provided with a psychiatric service dog and veterans on a waitlist to receive a service dog in terms of number and type of medications reported. However, veterans with a service dog were more likely to report that their doctor had decreased dosage or removed medications, as compared to veterans on the waitlist to acquire a service dog. “Our previous research has found that PTSD service dogs can improve specific areas of functioning and symptomology for military veterans. This new research builds on these findings by exploring how PTSD service dogs impact veterans’ medication use,” said study co-author Dr. Kerri Rodriguez, Postdoctoral Researcher at Colorado State University. “These results indicate that PTSD service dogs played a positive supporting role. Veterans kept up with their medication regimens, indicating that the presence of the service dog was not associated with any lapse in standard treatment. While having a PTSD service dog may not completely alleviate veterans’ needs for sleep, pain, or anxiety medications, there were reported decreases in dosage levels, shedding additional light on the potential value of these service dogs as a complimentary intervention.” The objective of this study was to quantify the effect of PTSD service dogs on medication use among a population of military veterans with PTSD. Fifty-two veterans living with a PTSD service dog and 44 veterans on a waitlist to receive a service dog were recruited from a database...

The Human Animal Bond Research Institute (HABRI) announced today that IDEXX Laboratories, Inc. has become an official supporter of HABRI and its research on the human health benefits of companion animals. “IDEXX is proud to support HABRI and its mission to advance human-animal bond research,” said Jonathan Ayers, Chairman and CEO of IDEXX Laboratories. “IDEXX is committed to enhancing the health and well-being of pets and people alike by bringing to market the most advanced diagnostics and software in veterinary medicine. When we provide high quality care for pets, human health also benefits.” “IDEXX is an innovative leader in pet health,” said Steven Feldman, Executive Director of HABRI. “By supporting HABRI, IDEXX is demonstrating its dedication to the human-animal bond and to keeping pets and people healthy together.” Scientific evidence increasingly shows that pets improve heart health; alleviate depression; increase well-being; support child health and development; and contribute to healthy aging. In addition, companion animals can assist in the treatment of a broad range of conditions from post-traumatic stress to Alzheimer’s disease to autism spectrum disorder. The benefits of the human-animal bond impact more than just human health. Findings from a recent HABRI survey of 2,000 pet owners demonstrate that knowledge of the scientific research on the human-animal bond motivates pet owners to take better care of their pets. From providing pets with higher quality nutrition to more frequent visits to the veterinarian, spreading awareness of the health benefits of pet ownership improves pet health and welfare.